Cargando…

Initial Clinical Experience with (90)Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients

Fibroblast activation protein (FAP) is overexpressed in several solid tumors and therefore represents an attractive target for radiotheranostic applications. Recent investigations demonstrated rapid and high uptake of small-molecule inhibitors of FAP ((68)Ga-FAPI-46) for PET imaging. Here, we report...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferdinandus, Justin, Costa, Pedro Fragoso, Kessler, Lukas, Weber, Manuel, Hirmas, Nader, Kostbade, Karina, Bauer, Sebastian, Schuler, Martin, Ahrens, Marit, Schildhaus, Hans-Ulrich, Rischpler, Christoph, Grafe, Hong, Siveke, Jens T., Herrmann, Ken, Fendler, Wolfgang P., Hamacher, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2022
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051597/ https://www.ncbi.nlm.nih.gov/pubmed/34385340 http://dx.doi.org/10.2967/jnumed.121.262468

Ejemplares similares

Safety and Efficacy of (90)Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities
por: Fendler, Wolfgang P., et al.
Publicado: (2022)

Equivalent tumor detection for early and late FAPI-46 PET acquisition
por: Ferdinandus, J., et al.
Publicado: (2021)

Superior Tumor Detection for (68)Ga-FAPI-46 Versus (18)F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
por: Pabst, Kim M., et al.
Publicado: (2023)

Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodeling
por: Siebermair, J., et al.
Publicado: (2020)

Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy
por: Pang, Yizhen, et al.
Publicado: (2023)

[(153)Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma
por: Kratochwil, Clemens, et al.
Publicado: (2021)

[(68)Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas
por: Guberina, Nika, et al.
Publicado: (2022)

Novel (68)Ga-FAPI PET/CT Offers Oncologic Staging Without COVID-19 Vaccine–Related Pitfalls
por: Demmert, Tristan T., et al.
Publicado: (2023)

Cardiac fibroblast activation detected by (68)Gallium-FAPI-46 positron emission tomography–magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosis
por: Siebermair, Johannes, et al.
Publicado: (2022)

Visualization of thermal damage using (68) Ga-FAPI-PET/CT after pulmonary vein isolation
por: Kupusovic, Jana, et al.
Publicado: (2021)

Subclass Analysis of Malignant, Inflammatory and Degenerative Pathologies Based on Multiple Timepoint FAPI-PET Acquisitions Using FAPI-02, FAPI-46 and FAPI-74
por: Glatting, Frederik M., et al.
Publicado: (2022)

Fibroblast activation protein targeted therapy using [(177)Lu]FAPI-46 compared with [(225)Ac]FAPI-46 in a pancreatic cancer model
por: Liu, Yuwei, et al.
Publicado: (2021)

Fully-automated production of [(68)Ga]Ga-FAPI-46 for clinical application
por: Spreckelmeyer, Sarah, et al.
Publicado: (2020)

Fully automated radiosynthesis of [(68)Ga]Ga-FAPI-46 with cyclotron produced gallium
por: Rosenberg, Adam J., et al.
Publicado: (2023)

Automated Synthesis of [(68)Ga]Ga-FAPI-46 on a Scintomics GRP Synthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2023)

Optimization of (177)Lu-labelling of DOTA-TOC, PSMA-I&T and FAPI-46 for clinical application
por: Cankaya, Aylin, et al.
Publicado: (2023)

First experiences with dynamic renal [(68)Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate
por: Kersting, David, et al.
Publicado: (2022)

Fibroblast Activation Protein-Targeted Radioligand Therapy with (177)Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study
por: Fu, Hao, et al.
Publicado: (2023)

Comparison of early and late (68)Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas
por: Hoppner, Jorge, et al.
Publicado: (2023)

Fully Automated Production of [(68)Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets
por: Fonseca, Alexandra I., et al.
Publicado: (2023)

Evaluation of improved attenuation correction in whole-body PET/MR on patients with bone metastasis using various radiotracers
por: Grafe, Hong, et al.
Publicado: (2020)

Translation and adaptation of functional auditory performance indicators (FAPI)
por: FERREIRA, Karina, et al.
Publicado: (2011)

Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer
por: Kersting, David, et al.
Publicado: (2021)

Visualization of fibroblast activation using (68)Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation
por: Kupusovic, Jana, et al.
Publicado: (2023)

Long-Term Complications of Radioligand Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms
por: Saracyn, Marek, et al.
Publicado: (2022)

Feasibility of [(68)Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Rabbit fever: granulomatous inflammation by Francisella tularensis mimics lung cancer in dual tracer (18)FDG and (68)Ga-FAPI PET/CT
por: Meetschen, Mathias, et al.
Publicado: (2023)

A case of [(68)Ga]Ga-FAPI-46-avid and [(18)F]F-FDG-negative COVID-19 pneumonia sequelae
por: Telo, Silvi, et al.
Publicado: (2022)

New Fully Automated Preparation of High Apparent Molar Activity (68)Ga-FAPI-46 on a Trasis AiO Platform
por: Da Pieve, Chiara, et al.
Publicado: (2022)

Imaging Inflammation with Positron Emission Tomography
por: Iking, Janette, et al.
Publicado: (2021)

Multimodal survival prediction in advanced pancreatic cancer using machine learning
por: Keyl, J., et al.
Publicado: (2022)

Head-to-Head Comparison of [(68) Ga]Ga-FAPI-46-PET/CT and [(18)F]F-FDG-PET/CT for Radiotherapy Planning in Head and Neck Cancer
por: Wegen, Simone, et al.
Publicado: (2022)

First Clinical Experience With [(68)Ga]Ga-FAPI-46-PET/CT Versus [(18)F]F-FDG PET/CT for Nodal Staging in Cervical Cancer
por: Wegen, Simone, et al.
Publicado: (2023)

FAPI-04 Uptake in Healthy Tissues of Cancer Patients in (68)Ga-FAPI-04 PET/CT Imaging
por: Gündoğan, Cihan, et al.
Publicado: (2021)

Ga68-FAPI Imaging and Lu177-FAPI Therapy in a Case of Metastatic Solitary Fibrous Tumor
por: Luthra, Karuna, et al.
Publicado: (2023)

Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from (68)Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
por: Weber, Manuel, et al.
Publicado: (2020)

Correlation between [(68)Ga]Ga-FAPI-46 PET Imaging and HIF-1α Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept
por: Mokoala, Kgomotso M. G., et al.
Publicado: (2023)

Evaluation of [(68)Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph vision
por: Weber, Manuel, et al.
Publicado: (2021)

1606P Developing a readiness assessment framework for radioligand therapy
por: Plucker, E., et al.
Publicado: (2020)

FAPI PET/CT Imaging—An Updated Review
por: Chandekar, Kunal Ramesh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8ehnfqrhk4j5n9lu8oua16plnl